ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry Q13873


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name BMPR2_HUMAN
Primary accession number Q13873
Secondary accession number Q16569
Integrated into Swiss-Prot on December 1, 2000
Sequence was last modified on December 1, 2000 (Sequence version 2)
Annotations were last modified on    July 22, 2008 (Entry version 96)
Name and origin of the protein
Protein name Bone morphogenetic protein receptor type-2 [Precursor]
Synonyms EC 2.7.11.30
Bone morphogenetic protein receptor type II
BMP type II receptor
BMPR-II
Gene name
Name: BMPR2
Synonyms: PPH1
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Substantia nigra;
PubMed=7644468 [NCBI, ExPASy, EBI, Israel, Japan]
Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C., Miyazono K.;
"Cloning and characterization of a human type II receptor for bone morphogenetic proteins.";
Proc. Natl. Acad. Sci. U.S.A. 92:7632-7636(1995).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Skin fibroblast;
DOI=10.1074/jbc.270.38.22522; PubMed=7673243 [NCBI, ExPASy, EBI, Israel, Japan]
Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wosing D.H., Rosenbaum J.S.;
"Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors.";
J. Biol. Chem. 270:22522-22526(1995).
[3]
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1074/jbc.270.10.5625; PubMed=7890683 [NCBI, ExPASy, EBI, Israel, Japan]
Kawabata M., Chytil A., Moses H.L.;
"Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor.";
J. Biol. Chem. 270:5625-5630(1995).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
VARIANTS PPH1 GLN-491 AND TRP-491.
DOI=10.1086/303059; PubMed=10903931 [NCBI, ExPASy, EBI, Israel, Japan]
Deng Z., Morse J.H., Slager S.L., Cuervo N., Moore K.J., Venetos G., Kalachikov S., Cayanis E., Fischer S.G., Barst R.J., Hodge S.E., Knowles J.A.;
"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.";
Am. J. Hum. Genet. 67:737-744(2000).
[6]
VARIANTS PPH1 TYR-60; TYR-117 AND ARG-483.
DOI=10.1136/jmg.37.10.741; PubMed=11015450 [NCBI, ExPASy, EBI, Israel, Japan]
Thomson J.R., Machado R.D., Pauciulo M.W., Morgan N.V., Humbert M., Elliott G.C., Ward K., Yacoub M., Mikhail G., Rogers P., Newman J.H., Wheeler L., Higenbottam T., Gibbs J.S.R., Egan J., Crozier A., Peacock A., Allcock R., Corris P., Loyd J.E., Trembath R.C., Nichols W.C.;
"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.";
J. Med. Genet. 37:741-745(2000).
[7]
VARIANTS PPH1 TRP-118; TYR-347 AND GLY-485.
DOI=10.1038/79226; PubMed=10973254 [NCBI, ExPASy, EBI, Israel, Japan]
Lane K.B., Machado R.D., Pauciulo M.W., Thomson J.R., Phillips J.A. III, Loyd J.E., Nichols W.C., Trembath R.C., Aldred M., Brannon C.A., Conneally P.M., Foroud T., Fretwell N., Gaddipati R., Koller D., Loyd E.J., Morgan N.V., Newman J.H., Prince M.A., Vilarino Gueell C., Wheeler L.;
"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.";
Nat. Genet. 26:81-84(2000).
[8]
VARIANTS PPH1 ARG-123; SER-123; ARG-420 AND THR-512, VARIANT ASP-224, AND CHARACTERIZATION OF VARIANT PPH1 GLY-485.
DOI=10.1086/316947; PubMed=11115378 [NCBI, ExPASy, EBI, Israel, Japan]
Machado R.D., Pauciulo M.W., Thomson J.R., Lane K.B., Morgan N.V., Wheeler L., Phillips J.A. III, Newman J.H., Williams D., Galie N., Manes A., McNeil K., Yacoub M., Mikhail G., Rogers P., Corris P., Humbert M., Donnai D., Martensson G., Tranebjaerg L., Loyd J.E., Trembath R.C., Nichols W.C.;
"BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.";
Am. J. Hum. Genet. 68:92-102(2001).
[9]
VARIANTS PPH1 HIS-82; ASP-182 AND ARG-483.
DOI=10.1183/09031936.02.01762002; PubMed=12358323 [NCBI, ExPASy, EBI, Israel, Japan]
Humbert M., Deng Z., Simonneau G., Barst R.J., Sitbon O., Wolf M., Cuervo N., Moore K.J., Hodge S.E., Knowles J.A., Morse J.H.;
"BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.";
Eur. Respir. J. 20:518-523(2002).
[10]
INVOLVEMENT IN PVOD.
PubMed=12446270 [NCBI, ExPASy, EBI, Israel, Japan]
Runo J.R., Vnencak-Jones C.L., Prince M., Loyd J.E., Wheeler L., Robbins I.M., Lane K.B., Newman J.H., Johnson J., Nichols W.C., Phillips J.A. III;
"Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.";
Am. J. Respir. Crit. Care Med. 167:889-894(2003).
[11]
VARIANT PPH1 PRO-899, AND CHARACTERIZATION OF VARIANT PPH1 PRO-899.
DOI=10.1002/humu.20200; PubMed=15965979 [NCBI, ExPASy, EBI, Israel, Japan]
Sankelo M., Flanagan J.A., Machado R., Harrison R., Rudarakanchana N., Morrell N., Dixon M., Halme M., Puolijoki H., Kere J., Elomaa O., Kupari M., Raeisaenen-Sokolowski A., Trembath R.C., Laitinen T.;
"BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.";
Hum. Mutat. 26:119-124(2005).
[12]
INVOLVEMENT IN PVOD.
DOI=10.1002/humu.20285; PubMed=16429395 [NCBI, ExPASy, EBI, Israel, Japan]
Machado R.D., Aldred M.A., James V., Harrison R.E., Patel B., Schwalbe E.C., Gruenig E., Janssen B., Koehler R., Seeger W., Eickelberg O., Olschewski H., Elliott C.G., Glissmeyer E., Carlquist J., Kim M., Torbicki A., Fijalkowska A., Szewczyk G., Parma J., Abramowicz M.J., Galie N., Morisaki H., Kyotani S., Nakanishi N., Morisaki T., Humbert M., Simonneau G., Sitbon O., Soubrier F., Coulet F., Morrell N.W., Trembath R.C.;
"Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.";
Hum. Mutat. 27:121-132(2006).
[13]
VARIANT [LARGE SCALE ANALYSIS] ASN-775.
DOI=10.1038/nature05610; PubMed=17344846 [NCBI, ExPASy, EBI, Israel, Japan]
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
Comments
  • FUNCTION: On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Binds to BMP-7, BMP-2 and, less efficiently, BMP-4. Binding is weak but enhanced by the presence of type I receptors for BMPs.
  • CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-protein] phosphate.
  • COFACTOR: Magnesium or manganese (By similarity).
  • INTERACTION:
    Q91X48:C4bp (xeno); NbExp=1; IntAct=EBI-527196, EBI-527325;
    P68404:Prkcb1 (xeno); NbExp=2; IntAct=EBI-527196, EBI-397048;
  • SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
  • TISSUE SPECIFICITY: Highly expressed in heart and liver.
  • DISEASE: Defects in BMPR2 are the cause of primary pulmonary hypertension (PPH1) [MIM:178600]. PPH1 is a rare autosomal dominant disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial PPH1 is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs.
  • DISEASE: Defects in BMPR2 are a cause of pulmonary venoocclusive disease (PVOD) [MIM:265450]. PVOD is a rare form of pulmonary hypertension in which the vascular changes originate in the small pulmonary veins and venules. The pathogenesis is unknown and any link with PPH1 has been speculative. The finding of PVOD associated with a BMPR2 mutation reveals a possible pathogenetic connection with PPH1.
  • SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.
  • SIMILARITY: Contains 1 protein kinase domain.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=BMPR2";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
Z48923; CAA88759.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D50516; BAA09094.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U20165; AAC50105.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC052985; AAH52985.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR I38935; I38935.
RefSeq NP_001195.2; -.
UniGene Hs.471119
3D structure databases
HSSP P36897; 1IAS. [HSSP ENTRY / PDB]
SMR Q13873; 33-131.
ModBase Q13873.
Protein-protein interaction databases
DIP DIP:5794N; -.
DIP:5941N; -.
DIP:5942N; -.
IntAct Q13873; -.
PTM databases
PhosphoSite Q13873; -.
Organism-specific databases
H-InvDB HIX0002749; -.
HGNC HGNC:1078; BMPR2.
GenAtlas BMPR2.
HPA HPA017385; -.
MIM 178600; phenotype. [NCBI / EBI]
265450; phenotype. [NCBI / EBI]
600799; gene. [NCBI / EBI]
Orphanet 422; Pulmonary arterial hypertension.
31837; Pulmonary venoocclusive disease.
PharmGKB PA25388; -.
GeneCards Q13873.
Gene expression databases
ArrayExpress Q13873; -.
CleanEx HS_BMPR2; -.
GermOnline ENSG00000204217; Homo sapiens.
Ontologies
GO
GO:0009986; Cellular component: cell surface (inferred from sequence or structural similarity from UniProtKB).
GO:0005887; Cellular component: integral to plasma membrane (inferred from direct assay from UniProtKB).
GO:0005515; Molecular function: protein binding (inferred from physical interaction from IntAct).
GO:0048286; Biological process: alveolus development (inferred from sequence or structural similarity from UniProtKB).
GO:0009952; Biological process: anterior/posterior pattern formation (inferred from sequence or structural similarity from UniProtKB).
GO:0030509; Biological process: BMP signaling pathway (inferred from direct assay from UniProtKB).
GO:0001707; Biological process: mesoderm formation (inferred from sequence or structural similarity from UniProtKB).
GO:0003085; Biological process: negative regulation of systemic arterial blood pressure (inferred from mutant phenotype from UniProtKB).
GO:0045906; Biological process: negative regulation of vasoconstriction (inferred from sequence or structural similarity from UniProtKB).
GO:0030501; Biological process: positive regulation of bone mineralization (inferred from mutant phenotype from UniProtKB).
GO:0045669; Biological process: positive regulation of osteoblast differentiation (inferred from mutant phenotype from UniProtKB).
GO:0042127; Biological process: regulation of cell proliferation (inferred from mutant phenotype from HGNC).
GO:0014916; Biological process: regulation of lung blood pressure (inferred from mutant phenotype from UniProtKB).
GO:0006366; Biological process: transcription from RNA polymerase II promoter (inferred from mutant phenotype from UniProtKB).
GO:0048010; Biological process: vascular endothelial growth factor receptor signaling pathway (inferred from sequence or structural similarity from UniProtKB).
QuickGo view.
Family and domain databases
InterPro IPR000472; Activin_rcpt.
IPR015770; BMPRII.
IPR000719; Prot_kinase_core.
IPR017441; Protein_kinase_ATP_bd_CS.
IPR017442; Se/Thr_pkinase-rel.
IPR008271; Ser_thr_pkin_AS.
Graphical view of domain structure.
PANTHER PTHR23255:SF12; BMPRII; 1.
Pfam PF01064; Activin_recp; 1.
PF00069; Pkinase; 1.
Pfam graphical view of domain structure.
ProDom PD000001; Prot_kinase; 1.
[Domain structure / List of seq. sharing at least 1 domain]
PROSITE PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PROSITE graphical view of domain structure (profiles).
BLOCKS Q13873.
Genome annotation databases
Ensembl ENSG00000204217; Homo sapiens. [Contig view]
GeneID 659; -.
KEGG hsa:659; -.
Phylogenomic databases
HOVERGEN Q13873; -.
Other
SOURCE BMPR2; Homo sapiens.
ProtoNet Q13873.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
ATP-binding; Disease mutation; Glycoprotein; Kinase; Magnesium; Manganese; Membrane; Metal-binding; Nucleotide-binding; Polymorphism; Receptor; Serine/threonine-protein kinase; Signal; Transferase; Transmembrane.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1     26  26     Potential. 
CHAIN   27   1038  1012     Bone morphogenetic protein receptor type-2. PRO_0000024415
TOPO_DOM   27    150  124     Extracellular (Potential). 
TRANSMEM   151    171  21     Potential. 
TOPO_DOM   172   1038  867     Cytoplasmic (Potential). 
DOMAIN   203    504  302     Protein kinase. 
NP_BIND   209    217  9     ATP (By similarity). 
COMPBIAS   547    550  4     Poly-Ser. 
COMPBIAS   610    618  9     Poly-Thr. 
COMPBIAS   901    908  8     Poly-Asn. 
ACT_SITE   333    333        Proton acceptor (By similarity). 
BINDING   230    230        ATP (By similarity). 
CARBOHYD   55     55        N-linked (GlcNAc...) (Potential). 
CARBOHYD   110    110        N-linked (GlcNAc...) (Potential). 
CARBOHYD   126    126        N-linked (GlcNAc...) (Potential). 
DISULFID   34     66        By similarity. 
DISULFID   94    117        By similarity. 
VARIANT   60     60  1     C -> Y (in PPH1). VAR_013670 [3D]
VARIANT   82     82  1     Q -> H (in PPH1). VAR_033109 [3D]
VARIANT   117    117  1     C -> Y (in PPH1). VAR_013671 [3D]
VARIANT   118    118  1     C -> W (in PPH1). VAR_013672 [3D]
VARIANT   123    123  1     C -> R (in PPH1). VAR_013673 [3D]
VARIANT   123    123  1     C -> S (in PPH1). VAR_013674 [3D]
VARIANT   182    182  1     G -> D (in PPH1). VAR_033110 
VARIANT   224    224  1     E -> D. VAR_013675 
VARIANT   347    347  1     C -> Y (in PPH1). VAR_013676 
VARIANT   420    420  1     C -> R (in PPH1). VAR_013677 
VARIANT   483    483  1     C -> R (in PPH1; sporadic). VAR_013678 
VARIANT   485    485  1     D -> G (in PPH1; complete loss of function). VAR_013679 
VARIANT   491    491  1     R -> Q (in PPH1; sporadic). VAR_013680 
VARIANT   491    491  1     R -> W (in PPH1). VAR_013681 
VARIANT   512    512  1     K -> T (in PPH1). VAR_013682 
VARIANT   519    519  1     N -> K (in PPH1). VAR_013683 
VARIANT   775    775  1     S -> N (in dbSNP:rs2228545 [NCBI]). VAR_019996 
VARIANT   899    899  1     R -> P (in PPH1; leads to constitutive activation of the MAPK14 pathway). VAR_033111 
CONFLICT   828    828        G -> R (in Ref. 1; CAA88759). 
Sequence information
Length: 1038 AA [This is the length of the unprocessed precursor] Molecular weight: 115201 Da [This is the MW of the unprocessed precursor] CRC64: 1389923CE574B913 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MTSSLQRPWR VPWLPWTILL VSTAAASQNQ ERLCAFKDPY QQDLGIGESR ISHENGTILC 

        70         80         90        100        110        120 
SKGSTCYGLW EKSKGDINLV KQGCWSHIGD PQECHYEECV VTTTPPSIQN GTYRFCCCST 

       130        140        150        160        170        180 
DLCNVNFTEN FPPPDTTPLS PPHSFNRDET IIIALASVSV LAVLIVALCF GYRMLTGDRK 

       190        200        210        220        230        240 
QGLHSMNMME AAASEPSLDL DNLKLLELIG RGRYGAVYKG SLDERPVAVK VFSFANRQNF 

       250        260        270        280        290        300 
INEKNIYRVP LMEHDNIARF IVGDERVTAD GRMEYLLVME YYPNGSLCKY LSLHTSDWVS 

       310        320        330        340        350        360 
SCRLAHSVTR GLAYLHTELP RGDHYKPAIS HRDLNSRNVL VKNDGTCVIS DFGLSMRLTG 

       370        380        390        400        410        420 
NRLVRPGEED NAAISEVGTI RYMAPEVLEG AVNLRDCESA LKQVDMYALG LIYWEIFMRC 

       430        440        450        460        470        480 
TDLFPGESVP EYQMAFQTEV GNHPTFEDMQ VLVSREKQRP KFPEAWKENS LAVRSLKETI 

       490        500        510        520        530        540 
EDCWDQDAEA RLTAQCAEER MAELMMIWER NKSVSPTVNP MSTAMQNERN LSHNRRVPKI 

       550        560        570        580        590        600 
GPYPDYSSSS YIEDSIHHTD SIVKNISSEH SMSSTPLTIG EKNRNSINYE RQQAQARIPS 

       610        620        630        640        650        660 
PETSVTSLST NTTTTNTTGL TPSTGMTTIS EMPYPDETNL HTTNVAQSIG PTPVCLQLTE 

       670        680        690        700        710        720 
EDLETNKLDP KEVDKNLKES SDENLMEHSL KQFSGPDPLS STSSSLLYPL IKLAVEATGQ 

       730        740        750        760        770        780 
QDFTQTANGQ ACLIPDVLPT QIYPLPKQQN LPKRPTSLPL NTKNSTKEPR LKFGSKHKSN 

       790        800        810        820        830        840 
LKQVETGVAK MNTINAAEPH VVTVTMNGVA GRNHSVNSHA ATTQYANGTV LSGQTTNIVT 

       850        860        870        880        890        900 
HRAQEMLQNQ FIGEDTRLNI NSSPDEHEPL LRREQQAGHD EGVLDRLVDR RERPLEGGRT 

       910        920        930        940        950        960 
NSNNNNSNPC SEQDVLAQGV PSTAADPGPS KPRRAQRPNS LDLSATNVLD GSSIQIGEST 

       970        980        990       1000       1010       1020 
QDGKSGSGEK IKKRVKTPYS LKRWRPSTWV ISTESLDCEV NNNGSNRAVH SKSSTAVYLA 

      1030 
EGGTATTMVS KDIGMNCL 

Q13873 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!